These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 24700330)

  • 21. Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults.
    Setyawan J; Hodgkins P; Guérin A; Gauthier G; Cloutier M; Wu E; Erder MH
    J Med Econ; 2013 Oct; 16(10):1203-15. PubMed ID: 23937642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD.
    Thiruchelvam D; Charach A; Schachar RJ
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):922-8. PubMed ID: 11501692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate.
    Hammerness P; Joshi G; Doyle R; Georgiopoulos A; Geller D; Spencer T; Petty CR; Faraone SV; Biederman J
    J Pediatr; 2013 Jan; 162(1):22-7.e2. PubMed ID: 22878114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration of effect of oral long-acting stimulant medications for ADHD throughout the day.
    Brams M; Moon E; Pucci M; López FA
    Curr Med Res Opin; 2010 Aug; 26(8):1809-25. PubMed ID: 20491612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications.
    Setyawan J; Guérin A; Hodgkins P; Gauthier G; Cloutier M; Wu E; Erder MH
    J Med Econ; 2013 Nov; 16(11):1275-89. PubMed ID: 24004347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulant treatment for children: a community perspective.
    Angold A; Erkanli A; Egger HL; Costello EJ
    J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):975-84; discussion 984-94. PubMed ID: 10939226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults.
    Brown TE; Brams M; Gao J; Gasior M; Childress A
    Postgrad Med; 2010 Sep; 122(5):7-17. PubMed ID: 20861583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional impairment and occupational outcome in adults with ADHD.
    Gjervan B; Torgersen T; Nordahl HM; Rasmussen K
    J Atten Disord; 2012 Oct; 16(7):544-52. PubMed ID: 21725028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Davis M; Mikami AY; Singh H; Merkel RL; Burket R
    J Clin Psychopharmacol; 2012 Apr; 32(2):225-30. PubMed ID: 22367664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulant medication for ADHD in opioid maintenance treatment.
    Abel KF; Bramness JG; Martinsen EW
    J Dual Diagn; 2014; 10(1):32-8. PubMed ID: 25392060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term treatment of ADHD with stimulants: a large observational study of real-life patients.
    Powell SG; Thomsen PH; Frydenberg M; Rasmussen H
    J Atten Disord; 2011 Aug; 15(6):439-51. PubMed ID: 20631198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES
    J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Author Correction: Differences between centers in functional outcome of patients with ADHD after 1 year from the time of diagnosis.
    Cartabia M; Finazzi S; Bonati M;
    Sci Rep; 2023 Dec; 13(1):22509. PubMed ID: 38110437
    [No Abstract]   [Full Text] [Related]  

  • 38. Regarding adult ADHD.
    Singh T
    Psychiatry (Edgmont); 2006 Oct; 3(10):64. PubMed ID: 20877549
    [No Abstract]   [Full Text] [Related]  

  • 39. A systematic review of interventions to support adults with ADHD at work-Implications from the paucity of context-specific research for theory and practice.
    Lauder K; McDowall A; Tenenbaum HR
    Front Psychol; 2022; 13():893469. PubMed ID: 36072032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal management of ADHD in older adults.
    Torgersen T; Gjervan B; Lensing MB; Rasmussen K
    Neuropsychiatr Dis Treat; 2016; 12():79-87. PubMed ID: 26811680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.